3-(4-BUTOXY-1,2,5-THIADIAZOL-3-YL)-1-METHYLPYRIDINIUM IODIDE
UNII GC2KW43L57

Substance Identification & Data

This profile provides standardized clinical and technical data for 3-(4-butoxy-1,2,5-thiadiazol-3-yl)-1-methylpyridinium Iodide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) GC2KW43L57.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 131988-14-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

GC2KW43L57

CAS Registry Number

131988-14-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

3-(4-BUTOXY-1,2,5-THIADIAZOL-3-YL)-1-METHYLPYRIDINIUM IODIDE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C12H16N3OS.I

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

OKTWHVBSBNCONO-UHFFFAOYSA-M

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

19075249

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

O(CCCC)c1c(nsn1)-c2c[n+](C)ccc2.[I-]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 3-(4-butoxy-1,2,5-thiadiazol-3-yl)-1-methylpyridinium Iodide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.